Wound Care News and Research

RSS

Derma Sciences implements reverse stock split for trading on NASDAQ Stock Market

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.

29 Jan 2010

RTI Biologics donates Matrix HD to treat eight-year-old with recessive dystrophic EB

RTI Biologics Inc. (RTI), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD™, to treat an eight-year old patient with a rare skin disease called recessive dystrophic epidermolysis bullosa (EB).

29 Jan 2010

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

28 Jan 2010

Australia issues patent covering Kane Biotech's DispersinB anti-biofilm technology

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce the issuance of Patent No. 2003284385 entitled "Compositions and methods for enzymatic detachment of bacterial and fungal biofilms" by IP Australia (Australian Patent and Trademark Office).

21 Jan 2010

Wound Care Innovations' CellerateRx highlighted at the SuperBones East conference

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations was highlighted as part of a presentation exhibited at the SuperBones East conference in Nassau, Bahamas, on January 14-17. The SuperBones Conference has a great reputation for high quality educational lectures and workshops and places top national speakers at the podium.

20 Jan 2010

KCI contributes advanced wound care products for the Haiti relief effort

Kinetic Concepts, Inc. today announced its contribution of more than $2 million dollars worth of advanced wound care products to the Haiti relief effort. The in-kind donation includes KCI’s industry-leading Active Healing SolutionsTM and Therapeutic Support SystemsTM products designed to help treat complex and hard-to-heal wounds. KCI will collaborate with Surgical Implant Generation Network (SIGN) and Project Medishare to place products in the hands of medical personnel in Haiti.

19 Jan 2010

Derma Sciences signs contract to produce finger bandages

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, has finalized a contract with a leading global healthcare products company to produce finger bandages

5 Jan 2010

Jamming bacterial communication may improve chronic wound care

Listening in on bacterial conversations could be the solution for improving chronic wound care, says a team of researchers at Binghamton University, State University of New York. Their findings have been published in the Journal of Applied Microbiology.

5 Jan 2010

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

24 Dec 2009

Smith & Nephew acquires property, manufacturing and operation assets of Nucryst Pharmaceuticals

The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE: SNN), announced today that its affiliates have completed the acquisition of substantially all of the assets of Nucryst Pharmaceuticals Corp. ("Nucryst").

22 Dec 2009

Derma Sciences receives licensing rights to wound and skin care products

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has completed a comprehensive Heads of Agreement with Comvita New Zealand Ltd. (Comvita) of Paengaroa, New Zealand, covering the worldwide licensing rights for MEDIHONEY® professional wound care and skin care products.

22 Dec 2009

Avery Dennison Specialty Tape's ultra-thin hydrocolloid adhesives deliver real consumer benefits

Avery Dennison Specialty Tape has developed a proprietary adhesive technology that adds significant value to consumer wound care products. Its newest generation of ultra-thin hydrocolloid adhesives delivers real consumer benefits in terms of better wear comfort, flexibility, longer wear time, less skin softening beneath the dressing, and gentle removal.

22 Dec 2009

HFU increases mortality among diabetics, says report

Cardium Therapeutics today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients.

17 Dec 2009

FDA grants marketing approval for EnzySurge's new SilverStream solution for prescription use

EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. The FDA also cleared DermaSept, an Over-the-Counter version of the SilverStream product.

15 Dec 2009

Winner Medical Group to implement SAP HCM

Winner Medical Group Inc., a leading manufacturer and exporter of medical, wound care and home care products in China, today announced that it will introduce SAP Human Capital Management (SAP HCM) on December 14, 2009 to systematize its human resource management.

10 Dec 2009

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today released an independent laboratory report indicating that the company's BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against the H1N1 virus.

10 Dec 2009

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

8 Dec 2009

Wound Management Technologies to market CellerateRx within the U.S.

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today an agreement with the Health Industry Representative Association (HIRA) to serve as a non-exclusive independent sales and marketing representative to market the company's core CellerateRx® product within the U.S.

4 Dec 2009

Foot ulcers: One of the many challenges of diabetics

Diabetics face many health challenges, and among them is the risk of developing foot ulcers.

25 Nov 2009

Shareholders approve Derma Sciences' reverse stock split

Derma Sciences, Inc. a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that its shareholders granted Derma Sciences' Board of Directors authority to implement a reverse stock split in the range of between 1-to-5 and 1-to-10.

25 Nov 2009

Wound Care News and Research

Derma Sciences implements reverse stock split for trading on NASDAQ Stock Market

RTI Biologics donates Matrix HD to treat eight-year-old with recessive dystrophic EB

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Australia issues patent covering Kane Biotech's DispersinB anti-biofilm technology

Wound Care Innovations' CellerateRx highlighted at the SuperBones East conference

KCI contributes advanced wound care products for the Haiti relief effort

Derma Sciences signs contract to produce finger bandages

Jamming bacterial communication may improve chronic wound care

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew acquires property, manufacturing and operation assets of Nucryst Pharmaceuticals

Derma Sciences receives licensing rights to wound and skin care products

Avery Dennison Specialty Tape's ultra-thin hydrocolloid adhesives deliver real consumer benefits

HFU increases mortality among diabetics, says report

FDA grants marketing approval for EnzySurge's new SilverStream solution for prescription use

Winner Medical Group to implement SAP HCM

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

Wound Management Technologies to market CellerateRx within the U.S.

Foot ulcers: One of the many challenges of diabetics

Shareholders approve Derma Sciences' reverse stock split

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News